Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.
Diabetes Obes Metab. 2016 Jan;18(1):40-8. doi: 10.1111/dom.12574. Epub 2015 Nov 5.
Diabetes Obes Metab. 2016.
PMID: 26343931
Free PMC article.
Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).
Buse JB, Vilsbøll T, Thurman J, Blevins TC, Langbakke IH, Bøttcher SG, Rodbard HW; NN9068-3912 (DUAL-II) Trial Investigators.
Buse JB, et al. Among authors: langbakke ih.
Diabetes Care. 2014 Nov;37(11):2926-33. doi: 10.2337/dc14-0785. Epub 2014 Aug 11.
Diabetes Care. 2014.
PMID: 25114296
Clinical Trial.
Item in Clipboard
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
King AB, Philis-Tsimikas A, Kilpatrick ES, Langbakke IH, Begtrup K, Vilsbøll T.
King AB, et al. Among authors: langbakke ih.
Diabetes Technol Ther. 2017 Apr;19(4):255-264. doi: 10.1089/dia.2016.0405. Epub 2017 Mar 10.
Diabetes Technol Ther. 2017.
PMID: 28282219
Free PMC article.
Clinical Trial.
Item in Clipboard
Pharmacokinetics and pharmacodynamics of growth hormone in patients on chronic haemodialysis compared with matched healthy subjects: an open, nonrandomized, parallel-group trial.
Langbakke IH, Nielsen JN, Skettrup MP, Harper A, Klitgaard T, Weil A, Engelhardt E, Lange M.
Langbakke IH, et al.
Clin Endocrinol (Oxf). 2007 Nov;67(5):776-83. doi: 10.1111/j.1365-2265.2007.02962.x. Epub 2007 Jul 18.
Clin Endocrinol (Oxf). 2007.
PMID: 17634080
Free PMC article.
Item in Clipboard
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial.
Koren MJ, Descamps O, Hata Y, Hengeveld EM, Hovingh GK, Ikonomidis I, Radu Juul Jensen MD, Langbakke IH, Martens FMAC, Søndergaard AL, Witkowski A, Koenig W.
Koren MJ, et al. Among authors: langbakke ih.
Lancet Diabetes Endocrinol. 2024 Mar;12(3):174-183. doi: 10.1016/S2213-8587(23)00325-X. Epub 2024 Feb 1.
Lancet Diabetes Endocrinol. 2024.
PMID: 38310920
Clinical Trial.
Item in Clipboard
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ.
Levy JH, et al. Among authors: langbakke ih.
Transfusion. 2006 Jun;46(6):919-33. doi: 10.1111/j.1537-2995.2006.00824.x.
Transfusion. 2006.
PMID: 16734808
Item in Clipboard
Cite
Cite